Latest | F'cast | |
---|---|---|
Div Yield | 3.1% | |
Div Cover | 0.8 | |
Op Mrgn | 21.7% | |
ROCE | 23.5% |
Latest | F'cast | |
---|---|---|
P/E | 39.2 | |
PEG | n/a | |
Pr/Revenue | 4.8 | |
Pr/Book | 27.3 |
Latest | F'cast | |
---|---|---|
Revenue | 18.6% | |
PBT | -41.3% | |
EPS | -39.3% | |
DPS | 5.7% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 25,424.00 | 8,133.00 | 1,240.00¢ | 18.5 | n/a | -4% | 656.00¢ | 2.9% |
31-Dec-21 | 25,979.00 | 6,701.00 | 1,034.00¢ | 21.8 | n/a | -17% | 722.00¢ | 3.2% |
31-Dec-22 | 26,323.00 | 7,346.00 | 1,218.00¢ | 21.6 | 1.2 | +18% | 795.00¢ | 3.0% |
31-Dec-23 | 28,190.00 | 7,855.00 | 1,256.00¢ | 22.9 | 7.6 | +3% | 864.00¢ | 3.0% |
31-Dec-24 | 33,424.00 | 4,609.00 | 762.00¢ | 34.2 | n/a | -39% | 913.00¢ | 3.5% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 35,703.54 | 15,710.27 | 2,107.57¢ | 14.2 | 0.1 | +177% | 1,064.46¢ | 0.0% |
31-Dec-26 | 36,306.72 | 15,856.66 | 2,160.18¢ | 13.8 | 5.5 | +2% | 1,020.75¢ | 0.0% |
31-Dec-27 | 37,268.63 | 16,063.12 | 2,241.73¢ | 13.3 | 3.5 | +4% | 1,062.14¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
SEP cashes in as US giant Amgen buys cancer drug... | 26-Jan-2011 | The Scotsman |
Amgen Buys a Cancer Drug Maker | 25-Jan-2011 | New York Times |
Tech Ticker | 16-Dec-2010 | BayArea.com |
Currency | US Dollars |
Share Price | $ 298.81 |
Change Today | $ 3.00 |
% Change | 1.01 % |
52 Week High | $327.36 |
52 Week Low | $258.59 |
Volume | 1,959,530 |
Shares Issued | 536.90m |
Market Cap | $160,431m |
RiskGrade | 100 |
Strong Buy | 6 |
Buy | 7 |
Neutral | 15 |
Sell | 2 |
Strong Sell | 1 |
Total | 31 |
Time | Volume / Share Price |
15:59 | 100 @ $298.81 |
15:59 | 100 @ $298.81 |
15:59 | 100 @ $298.81 |
15:59 | 100 @ $298.81 |
15:59 | 100 @ $298.81 |
You are here: research